Evidence map›Paper›PMID 40943549›Full record

ReviewInternational journal of molecular sciences2025

Melanosome Transport and Processing in Skin Pigmentation: Mechanisms and Targets for Pigmentation Modulation.

Mengjing Bao, Mathias Gempeler, Remo Campiche

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Moranoline-EnrichedInternational journal of molecular sciences · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Global Emergence ofInfection and drug resistance · 2026
    Review
  10. Disrupting melanin transfer: innovative strategy for anti-pigmentation drug discovery.Journal of enzyme inhibition and medicinal chemistry · 2025
    Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mengjing BaoDSM-Firmenich, Wurmisweg 576, 4303 Kaiseraugst, Switzerland.ORCID 0000-0002-5523-2314
Mathias GempelerDSM-Firmenich, Wurmisweg 576, 4303 Kaiseraugst, Switzerland.
Remo CampicheDSM-Firmenich, Wurmisweg 576, 4303 Kaiseraugst, Switzerland.ORCID 0000-0002-2216-7851

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Achieving even skin tone and controlling pigmentation are key goals in dermocosmetics, given the impact of disorders like melasma, post-inflammatory hyperpigmentation, and age spots. The process of pigmentation begins with melanin synthesis within melanosomes, specialized organelles in melanocytes. Once produced, melanin is transferred to neighboring keratinocytes, where it forms protective caps over cell nuclei before undergoing eventual degradation. Disruptions at any stage of this complex process, whether in melanin production, melanosome transport, or post-transfer processing, can lead to visible pigmentation irregularities. While traditional treatments primarily focus on inhibiting melanin production (e.g., through tyrosinase inhibitors), emerging research highlights the important role of melanosome transport and keratinocyte-mediated processing in determining visible pigmentation. This review focuses on the underexplored stages of melanosome transport, transfer, and keratinocyte-mediated processing as promising targets for therapeutic and cosmetic strategies in managing pigmentation disorders.

Indexed as

MelanosomesSkin PigmentationAnimalsBiological TransportHumansKeratinocytesMelaninsMelanocytesMelaninsmelanin degradationmelanogenesismelanosome transfermelanosome transport

Identifiers

PMID40943549
PMCPMC12429606

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.